Renescience A/S: Financial statements 2017
CVR: 31846803
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Renescience A/S (CVR 31846803) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -9,657,000 and a net result of DKK -7,760,000 compared with DKK -29,521,000 the year before. Equity in the 2017 report amounted to DKK 81,786,000. The solvency ratio was 91.6%.
- Gross Profit
- DKK -9,657,000
- Profit/Loss
- DKK -7,760,000
- Equity
- DKK 81,786,000
- Total Assets
- DKK 89,250,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -9.7 mio. | -7.8 mio. | 81.8 mio. | - |
| 2016 | - | -37.1 mio. | -29.5 mio. | 89.5 mio. | - |
| 2015 | - | -56 mio. | -43.2 mio. | 24.1 mio. | - |
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
Official annual report
Keep an eye on Renescience A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
On October 30, 2017, the company changed its name from RENESCIENCE A/S to Renescience A/S.
As of June 8, 2017, Mikael Brandt has joined the board of directors of Renescience A/S.
As of June 8, 2017, Jacob Moesgård has left the board of directors of Renescience A/S.
Renescience A/S has published its annual report for 2016. Gross profit came to DKK -37,068,000, and the net result was DKK -29,521,000.
As of February 23, 2017, Hannes Reuter is registered as director of Renescience A/S.
As of February 23, 2017, Anna-Lena Elisabet Jeppsson has stepped down as director of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.